Annual report
Page 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ( Mark One ) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 or □ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number : 001-01011 ♥ CVSHealth CVS HEALTH CORPORATION ( Exact name of registrant as specified in its charter ) Delaware ( State or other jurisdiction of incorporation or organization ) One CVS Drive , Woonsocket , Rhode Island ( Address of principal executive offices ) Registrant's telephone number , including area code : Securities registered pursuant to Section 12 ( b ) of the Act : Title of each class Trading Symbol ( s ) CVS ☐ ( I.R.S. Employer Identification No. ) 05-0494040 Common Stock , par value $ 0.01 per share Securities registered pursuant to Section 12 ( g ) of the Act : Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . None 02895 ( Zip Code ) ( 401 ) 765-1500 Name of each exchange on which registered New York Stock Exchange Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See the definitions of " large accelerated filer , ” “ accelerated filer , " " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Large accelerated filer Non - accelerated filer As of February 8 , 2021 , the registrant had 1,311,354,926 shares of common stock outstanding . DOCUMENTS INCORPORATED BY REFERENCE Yes Yes Accelerated filer Smaller reporting company Emerging growth company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Yes Yes Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . Yes No No The following materials are incorporated by reference into this Form 10 - K : Information contained in the definitive proxy statement for CVS Health Corporation's 2021 Annual Meeting of Stockholders , to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year ended December 31 , 2020 ( the " Proxy Statement " ) , is incorporated by reference in Parts III and IV to the extent described therein . No No 000 The aggregate market value of the registrant's common stock held by non - affiliates was approximately $ 84,719,366,378 as of June 30 , 2020 , based on the closing price of the common stock on the New York Stock Exchange . For purposes of this calculation , only executive officers and directors are deemed to be affiliates of the registrant . 0 No